Become a digitalPLUS subscriber. $12 for 12 weeks.


Pfizer's interest in AstraZeneca worries Maryland
Pfizer's interest in AstraZeneca worries Maryland

Research labs closed by pharmaceutical giant Pfizer dot the country: Illinois. Michigan. New Jersey. New York. North Carolina. Maryland officials don't want this state to join that list. After Pfizer declared its desire to buy AstraZeneca — which employs 3,100 in the state — Gov. Martin O'Malley and six members of Maryland's congressional delegation fired off concerned letters, even though the purchase is by no means a done deal. So far, London-based AstraZeneca has rebuffed its New York suitor. Yet O'Malley pressed Pfizer for assurances on jobs, noting that the company made some employment promises to the United Kingdom. Pfizer's response:...